Risk Factors and Comorbidities in Young Indian Patients with Hypertension: REAL YOUNG (Hypertension) Study.
diabetes mellitus
dyslipidemia
prevalence
young population
Journal
Integrated blood pressure control
ISSN: 1178-7104
Titre abrégé: Integr Blood Press Control
Pays: New Zealand
ID NLM: 101562709
Informations de publication
Date de publication:
2021
2021
Historique:
received:
17
07
2020
accepted:
29
10
2020
entrez:
5
3
2021
pubmed:
6
3
2021
medline:
6
3
2021
Statut:
epublish
Résumé
To analyze the risk factors and comorbidities among the young Indian adults with hypertension. This was a retrospective, multicentric real-world study which included patients diagnosed with and receiving treatment for hypertension. Data were collected from the medical records of clinics/hospitals across 623 study sites in India. Patients of either sex and aged 18-45 years were included. Demographic details (age, sex, anthropometric measurement), medical and family history, sedentary lifestyle, smoking status and alcohol consumption data were extracted. Descriptive and comparative analysis (Mann-Whitney Out of 15,006 young patients diagnosed with hypertension (men=63.6%), 65.7% belonged to the age group of >35-45 years. The median body mass index was 27.0 kg/m The results showed that among the young population, hypertension was common in the age group of >35-45 years and diabetes mellitus and dyslipidemia were common comorbidities. Family history, sedentary lifestyle, smoking, alcohol consumption, and body mass index may also contribute to hypertension.
Identifiants
pubmed: 33664586
doi: 10.2147/IBPC.S272548
pii: 272548
pmc: PMC7924245
doi:
Types de publication
Journal Article
Langues
eng
Pagination
31-41Informations de copyright
© 2021 Desai et al.
Déclaration de conflit d'intérêts
Dr Mahesh Abhyankar and Dr Santosh Revankar are employees of USV Pvt. Ltd. Mahesh V Abhyankar reports personal fees from USV Pvt. Ltd, during the conduct of the study. The authors report no other conflicts of interest in this work.
Références
Am J Epidemiol. 2004 Jun 15;159(12):1168-79
pubmed: 15191934
PLoS One. 2018 Feb 5;13(2):e0191948
pubmed: 29401464
Heliyon. 2020 Feb 08;6(2):e03383
pubmed: 32072063
Lancet. 2005 Jan 15-21;365(9455):217-23
pubmed: 15652604
Trop Med Int Health. 2019 Nov;24(11):1301-1310
pubmed: 31465584
J Hypertens. 2016 Aug;34(8):1473-9
pubmed: 27270189
ISRN Prev Med. 2012 Dec 03;2013:574973
pubmed: 24967139
J Epidemiol. 2012;22(4):317-23
pubmed: 22672914
JAMA Intern Med. 2018 Mar 1;178(3):363-372
pubmed: 29379964
Int J Hypertens. 2017;2017:9656450
pubmed: 29230325
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
J Hypertens. 2014 Jun;32(6):1170-7
pubmed: 24621804
JAMA. 1979 Jan 5;241(1):43-6
pubmed: 758494
Diabetes Metab Syndr. 2015 Jan-Mar;9(1):38-41
pubmed: 25470638
PLoS Med. 2019 May 3;16(5):e1002801
pubmed: 31050680
Am J Cardiol. 1992 Oct 29;70(12):14D-20D
pubmed: 1414920
BMC Public Health. 2015 Jun 20;15:576
pubmed: 26092387
J Clin Hypertens (Greenwich). 2017 Jun;19(6):603-610
pubmed: 28444926
Diabetes Technol Ther. 2012 Jan;14(1):8-15
pubmed: 22050271
Hypertension. 2018 Jun;71(6):1269-1324
pubmed: 29133354
Indian Heart J. 2019 Jul - Aug;71(4):309-313
pubmed: 31779858